TrialJournal of gynecologic oncology2024

A phase 1/2a, dose-escalation, safety, and preliminary efficacy study of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2.

Hyun-Woong Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.